|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.994
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.988
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.968
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.961
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.937
|
Human |
|
|
fibril organization
|
GO:0097435 |
2 |
0.933
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.931
|
Mouse |
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.850
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.836
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.764
|
Mouse |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.761
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.740
|
Human |
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.735
|
|
|
|
aorta smooth muscle tissue morphogenesis
|
GO:0060414 |
2 |
0.706
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.703
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.635
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.616
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.608
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.573
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.571
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.568
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.555
|
Mouse |
|
|
limb bud formation
|
GO:0060174 |
10 |
0.548
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.546
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.534
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.522
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.506
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.497
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.492
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.486
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.486
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.484
|
Human |
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.479
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.476
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.475
|
Mouse |
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.469
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.468
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.442
|
Human |
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.441
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.432
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.426
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.425
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.415
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.413
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.412
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.408
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.394
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.384
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.384
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.377
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.359
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.344
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.341
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.339
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.335
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.327
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.324
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.323
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.319
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.319
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.311
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.304
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.291
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.286
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.278
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.277
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.271
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.269
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.263
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.253
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.251
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.249
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.242
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.241
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.238
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.234
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.231
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.228
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.222
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.221
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.221
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.220
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.216
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.215
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.215
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.209
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.205
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.202
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.199
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.196
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.190
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.189
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.189
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.187
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.183
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.180
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.177
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.176
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.174
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.172
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.172
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.171
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.171
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.171
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.170
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.165
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.162
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.161
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.159
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.155
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.154
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.151
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.144
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.140
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.140
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.137
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.136
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.136
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.132
|
|
|
|
aorta development
|
GO:0035904 |
23 |
0.127
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.122
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.121
|
|
|
|
otic vesicle development
|
GO:0071599 |
14 |
0.117
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.114
|
Mouse |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.109
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.109
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.107
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.105
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.103
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.103
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.101
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.101
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.100
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.100
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.100
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.100
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.098
|
|
|
|
face development
|
GO:0060324 |
38 |
0.097
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.095
|
|
|
|
endodermal cell differentiation
|
GO:0035987 |
14 |
0.093
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.090
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.090
|
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.089
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.089
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.089
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.088
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.087
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.086
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.086
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.084
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.083
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.082
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.082
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.081
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.080
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.078
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.076
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.075
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.075
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.074
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.074
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.073
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.073
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.071
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.071
|
|
|
|
tendon development
|
GO:0035989 |
6 |
0.071
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.070
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.070
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.069
|
Mouse |
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.068
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.067
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.066
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.066
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.066
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.064
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.064
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.064
|
|
|
|
direct ossification
|
GO:0036072 |
5 |
0.063
|
|
|
|
lateral ganglionic eminence cell proliferation
|
GO:0022018 |
1 |
0.061
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.060
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.059
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.059
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.059
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.058
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.058
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.057
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.056
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.056
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.055
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.053
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.052
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.052
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.049
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.047
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.046
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
7 |
0.046
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.046
|
|
|
|
macrophage chemotaxis
|
GO:0048246 |
14 |
0.044
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.044
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.043
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.043
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.042
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.041
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.041
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.041
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.041
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.040
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.040
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.040
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.038
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.038
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.037
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.037
|
|
|
|
negative regulation of neuron migration
|
GO:2001223 |
6 |
0.037
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.037
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.036
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.036
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.036
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.035
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.035
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.035
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.034
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.034
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.034
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.033
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.033
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.033
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.033
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.033
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.032
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.031
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.031
|
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
7 |
0.031
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.031
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.030
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.030
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.030
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.030
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.030
|
|
|
|
basement membrane assembly
|
GO:0070831 |
2 |
0.029
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.029
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.029
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.029
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.028
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.028
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.028
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.027
|
|
|
|
regulation of protein import into nucleus translocation
|
GO:0033158 |
2 |
0.027
|
|
|
|
positive regulation of bone resorption
|
GO:0045780 |
13 |
0.027
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.027
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.027
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.026
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.026
|
|
|
|
positive regulation of adiponectin secretion
|
GO:0070165 |
1 |
0.026
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.026
|
|
|
|
antibacterial humoral response
|
GO:0019731 |
8 |
0.026
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.026
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.026
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.025
|
|
|
|
regulation of hepatocyte proliferation
|
GO:2000345 |
6 |
0.025
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.025
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.025
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.025
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.025
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.025
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.024
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.024
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.023
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.023
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.023
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.023
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.022
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.022
|
|
|
|
sequestering of bmp in extracellular matrix
|
GO:0035582 |
3 |
0.022
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.022
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.022
|
|
|
|
negative regulation of endodermal cell differentiation
|
GO:1903225 |
1 |
0.022
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.022
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.021
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
response to symbiont
|
GO:0009608 |
2 |
0.021
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.021
|
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.021
|
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.021
|
|
|
|
peptide cross linking via chondroitin 4 sulfate glycosaminoglycan
|
GO:0019800 |
8 |
0.021
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.021
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.021
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.021
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.021
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.020
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.020
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.020
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.020
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.020
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.020
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.019
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.019
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.019
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.019
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.019
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.019
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.019
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.019
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.019
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.019
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.018
|
|
|
|
regulation of macrophage migration inhibitory factor signaling pathway
|
GO:2000446 |
1 |
0.018
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.018
|
|
|
|
pma inducible membrane protein ectodomain proteolysis
|
GO:0051088 |
1 |
0.018
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.018
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.018
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.018
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.018
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.018
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
7 |
0.018
|
|
|
|
positive regulation of tissue remodeling
|
GO:0034105 |
19 |
0.018
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.018
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.018
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.018
|
|
|
|
negative regulation of embryonic development
|
GO:0045992 |
22 |
0.018
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.018
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.018
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.018
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.017
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.017
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.017
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.017
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.017
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.017
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.017
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.017
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.017
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.016
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.016
|
|
|
|
regulation of transmission of nerve impulse
|
GO:0051969 |
1 |
0.016
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.016
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.016
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.016
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.016
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.016
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.016
|
|
|
|
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation
|
GO:0021938 |
4 |
0.016
|
|
|
|
negative regulation of interleukin 10 secretion
|
GO:2001180 |
2 |
0.016
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.015
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.015
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.015
|
|
|
|
negative regulation of biomineral tissue development
|
GO:0070168 |
11 |
0.015
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.015
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.015
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.015
|
|
|
|
otolith morphogenesis
|
GO:0032474 |
3 |
0.015
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.015
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.015
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.015
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.015
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.015
|
|
|
|
response to monoamine
|
GO:0071867 |
4 |
0.015
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.014
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.014
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.014
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.014
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.014
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.014
|
|
|
|
coronary vasculature development
|
GO:0060976 |
12 |
0.014
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.014
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.014
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.014
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.014
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.014
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.014
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
|
regulation of superoxide metabolic process
|
GO:0090322 |
8 |
0.014
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.014
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.014
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.014
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.013
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.013
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.013
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.013
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.013
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.013
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.013
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.013
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.013
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.013
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.013
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.013
|
|
|
|
frontal suture morphogenesis
|
GO:0060364 |
2 |
0.013
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.013
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.013
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.013
|
|
|
|
negative regulation of lipoprotein lipase activity
|
GO:0051005 |
1 |
0.013
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.013
|
|
|
|
regulation of gastrulation
|
GO:0010470 |
16 |
0.013
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.013
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.013
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.013
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.013
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.013
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.013
|
|
|
|
epithelial cell proliferation involved in prostatic bud elongation
|
GO:0060517 |
1 |
0.012
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.012
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.012
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.012
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.012
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.012
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.012
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.012
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.012
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.012
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.012
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.012
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.012
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.012
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.012
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.012
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.012
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.012
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.011
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.011
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.011
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.011
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.011
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.011
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.011
|
|
|
|
cell migration involved in metanephros development
|
GO:0035788 |
2 |
0.011
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.011
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.011
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.011
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.011
|
|
|
|
collagen catabolic process
|
GO:0030574 |
6 |
0.011
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.011
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.011
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.011
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.011
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.011
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.011
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.011
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.011
|
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
25 |
0.011
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.011
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.011
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.011
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.011
|
|
|
|
dermatome development
|
GO:0061054 |
1 |
0.011
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.011
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.011
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
42 |
0.010
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.010
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.010
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.010
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.010
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.010
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.010
|
|